| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |